Neurocrine Biosciences Inc Stock Performance
as on April 15, 2026 at 6:59 am IST
Day's Low
Day's High
$126.48$130.82
3.32%
Downside
-0.01%
Upside
52 Week's Low
52 Week's High
$92.31$160.1829.44%
Downside
22.43%
Upside
Neurocrine Biosciences Inc share price movements today
- Previous Close
- $126.32
- Open
- $127.20
- Volume
- 749.6K
- Day's Low - High
- $126.48 - $130.82
- 52 Week Low - High
- $92.31 - $160.18
Neurocrine Biosciences Inc Historical Returns
- 1 Month Return
- -2.67 %
- 3 Month Return
- -6.66 %
- 1 Year Return
- + 33.12 %
- 3 Year Return
- + 22.9 %
- 5 Year Return
- + 32.9 %
Neurocrine Biosciences Inc Stock Fundamentals & Key Indicators
Check Neurocrine Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$12.9B
EPS (TTM)
7.674
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.48%
PE Ratio (TTM)
27.6
Industry PE ratio
22.96
PEG Ratio
0.4178
EBITDA
666.6M
Revenue (TTM)
2.9B
Profit Margin
16.73%
Return On Equity TTM
16.38%
Neurocrine Biosciences Inc Stock Valuation
Track how Neurocrine Biosciences Inc P/E has moved over time to understand its valuation trends.
Neurocrine Biosciences Inc in the last 5 years
Lowest (19.60x)
June 30, 2025
Industry (22.96x)
April 14, 2026
Today (27.60x)
April 14, 2026
Highest (178.01x)
September 30, 2022
Today’s Price to Earnings Ratio: 27.60x
Neurocrine Biosciences Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurocrine Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $12.9B | 32.9% | 27.6 | 16.73% | |
| NA | $14.3B | NA | NA | 0.00% | |
| BUY | $25.3B | NA | 20.75 | 41.94% | |
| HOLD | $15.7B | 4.69% | NA | -24.58% | |
| BUY | $43.9B | NA | 19.68 | 15.11% |
Stock Returns calculator for Neurocrine Biosciences Inc Stock including INR - Dollar returns
The Neurocrine Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Neurocrine Biosciences Inc investment value today
Current value as on today
₹1,49,145
Returns
₹49,145
(+49.15%)
Returns from Neurocrine Biosciences Inc Stock
₹37,875 (+37.88%)
Dollar Impact
₹11,270 (+11.27%)
Analyst Recommendation on Neurocrine Biosciences Inc Stock
Based on 34 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Neurocrine Biosciences Inc. Average target price of $184.73
Neurocrine Biosciences Inc Share Price Target
Get share price movements and forecasts by analysts on Neurocrine Biosciences Inc.
What analysts predicted
29.18%UPSIDE
Target Price
$184.73
Current Price
$130.83
Analyzed by
34 Analysts
Target
$184.73
Neurocrine Biosciences Inc target price $184.73, a slight upside of 29.18% compared to current price of $130.83. According to 34 analysts rating.
Neurocrine Biosciences Inc Stock’s Investor Sentiment and Interest
Search interest for Neurocrine Biosciences Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Neurocrine Biosciences Inc Quarterly Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc Annual Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc Quarterly Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc Annual Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc News & Key Events
Today's Timeline - 06 April
Mon, 09:05 PM
-Neurocrine agrees to acquire Soleno for $2.9 billion, offering $53 per share, a 34% premium over Soleno's closing price.
Tue, 03:10 AM
-Neurocrine reinforces its rare-disease drug portfolio by acquiring Soleno and its VYKAT XR treatment for hyperphagia.
Insights on Neurocrine Biosciences Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 572.6M → 805.5M (in $), with an average increase of 10.5% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 3695.2% return, outperforming this stock by 3663.8%
- NO EFFECT
Against Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 4275.7% return, outperforming this stock by 4252.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 209.5M → 153.7M (in $), with an average decrease of 26.6% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, NBIX stock has moved down by -5.1%
About Neurocrine Biosciences Inc
| Organisation | Neurocrine Biosciences Inc |
| Headquarters | 6027 Edgewood Bend Court, San Diego, CA, United States, 92130 |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Mr. Kyle W. Gano Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Neurocrine Biosciences Inc
Name | Title |
|---|---|
Mr. Lewis Choi | Chief Information Officer |
Mr. Kyle W. Gano Ph.D. | President, CEO & Director |
Dr. Wylie W. Vale Ph.D. | Co-Founder |
Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder of Neurocrine |
Mr. Todd Tushla | Vice President of Investor Relations |
Mr. Darin M. Lippoldt Esq. | Chief Legal Officer & Corporate Secretary |
Ms. Julie S. Cooke | Chief Human Resources Officer |
Dr. Jude Onyia Ph.D. | Chief Scientific Officer |
Mr. Eric S. Benevich | Chief Commercial Officer |
Dr. Eiry Wyn Roberts M.D. | Strategic Advisor |
FAQs
What is Neurocrine Biosciences Inc share price today?
Neurocrine Biosciences Inc share price today is $130.83 as on at the close of the market. Neurocrine Biosciences Inc share today touched a day high of $130.82 and a low of $126.48.
What is the 52 week high and 52 week low for Neurocrine Biosciences Inc share?
Neurocrine Biosciences Inc share touched a 52 week high of $160.18 on and a 52 week low of $92.31 on . Neurocrine Biosciences Inc stock price today i.e. is closed at $130.83,which is 18.32% down from its 52 week high and 41.73% up from its 52 week low.
What is Neurocrine Biosciences Inc's market capitalisation today?
Neurocrine Biosciences Inc market capitalisation is $0.01T as on .
How to invest in Neurocrine Biosciences Inc Stock (NBIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurocrine Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurocrine Biosciences Inc Shares that will get you 0.0115 shares as per Neurocrine Biosciences Inc share price of $130.83 per share as on April 15, 2026 at 1:29 am IST.
What is the minimum amount required to buy Neurocrine Biosciences Inc Stock (NBIX) from India?
Indian investors can start investing in Neurocrine Biosciences Inc (NBIX) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Neurocrine Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurocrine Biosciences Inc share’s latest price of $130.83 as on April 15, 2026 at 1:29 am IST, you will get 0.0764 shares of Neurocrine Biosciences Inc. Learn more about
fractional shares .
What are the returns that Neurocrine Biosciences Inc has given to Indian investors in the last 5 years?
Neurocrine Biosciences Inc stock has given 32.9% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?